Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

During the Trading Day
70.02 +2.49 / +3.69%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
70.02 0.00 / 0.00%
 
Volume: 15.1K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$10.3B

Company Description

Alkermes Plc is a biopharmaceutical company, which engages in the development, manufacturing and distribution of medicines. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system disorders such as addiction, schizophrenia and depression. Alkermes was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Alkermes Plc
Connaught House
Dublin Dublin 4
P:(531) 772-8000
Investor Relations:
(781) 609-6378

Employees

Shareholders

Mutual fund holders71.27%
Other institutional26.91%
Individual stakeholders0.87%

Top Executives

Richard F. PopsChairman & Chief Executive Officer
Shane M. CookePresident
Gordon G. PughSenior VP, Chief Operating & Risk Officer
James M. FratesChief Financial Officer, Treasurer & Senior VP
Elliot W. EhrichChief Medical Officer, EVP-Research & Development